Title: Holzer P, et al. Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors. J Med Chem. 2015 Aug 27;58(16):6348-58.
1313363-54-0
1313363-86-8
1398065-96-7 | Bis(2-butoxyethyl)Phthalate-d4 | AA01E1VD | MFCD22565793
152323-00-7 | D,L-DropropizineN-Oxide | AA01E286
89921-51-7 | 3-oxatricyclo[3.2.1.0,2,4]octane-6,7-diol | AA01E2M8 | MFCD31666075
1902957-95-2 | PosaconazolePiperazineDioxide | AA01E3G4
23929-50-2 | 17β-Estradiol17-SulfatePotassiumSalt | AA01E3SY
433249-94-6 | 3-[(2,5-Dimethylphenyl)amino]-1-phenyl-2-propen-1-one | AA01E4EN | MFCD02911570
6064-90-0 | MethylHeneicosanoate | AA01E4RC | MFCD00009345
857054-06-9 | 3,7-Dimethyl2H-Furo[2,3-c]pyran-2-one | AA01E5F6 | MFCD18382304
94051-08-8 | Quizalofop-P | AA01E5UJ | MFCD00872025
1338-02-9 | Copper naphthenate | AA01E6HJ | MFCD00146564